We are live on
!
Find out more
BS
Boenning & Scattergood Portfolio holdings
AUM
$622M
1-Year Est. Return
8.79%
This Fund
S&P 500
This Quarter
Est. Return
+11.62%
1 Year Est. Return
-8.79%
3 Year Est. Return
+34.52%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$334M
AUM Growth
+$47.3M
(+17%)
Cap. Flow
+$13.4M
Cap. Flow
% of AUM
4.02%
Top 10 Holdings %
Top 10 Hldgs %
23.72%
Holding
289
New
27
Increased
129
Reduced
87
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$2.41M |
| 2 |
CVS Health
CVS
|
+$1.67M |
| 3 |
Wells Fargo
WFC
|
+$1.58M |
| 4 |
Target
TGT
|
+$1.34M |
| 5 |
AbbVie
ABBV
|
+$1.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UHT
Universal Health Realty Income Trust
UHT
|
+$5.13M |
| 2 |
iShares Biotechnology ETF
IBB
|
+$1.13M |
| 3 |
GSK
GSK
|
+$934K |
| 4 |
KL
Kirkland Lake Gold Ltd Ordinary
KL
|
+$732K |
| 5 |
General Motors
GM
|
+$713K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.34% |
| 2 | Technology | 13% |
| 3 | Industrials | 10.2% |
| 4 | Financials | 9.85% |
| 5 | Energy | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
McCormick & Company Non-Voting
MKC
$13.7B
| $292K | 0.09% |
3,880
-134
| -3% | -$9.04K |
|
227
Coty
COTY
$2.42B
| $290K | 0.09% |
25,225
+1,150
| +5% | +$10.9K |
|
228
Aflac
AFL
$64.9B
| $289K | 0.09% |
5,778
+1,280
| +28% | +$61.7K |
|
229
Fulton Financial
FULT
$4.66B
| $287K | 0.09% |
18,546
| – | – |
|
230
Cigna
CI
$73.7B
| $285K | 0.09% |
1,770
+220
| +14% | +$40.2K |
|
231
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.83B
| $281K | 0.08% |
3,580
-92
| -3% | -$7.12K |
|
232
BP
BP
$116B
| $277K | 0.08% |
6,444
-4,779
| -43% | -$196K |
|
|
SOR
233
Source Capital
SOR
$383M
| $276K | 0.08% |
7,668
+28
| +0.4% | +$985 |
|
234
Blackstone
BX
$102B
| $273K | 0.08% |
7,803
+34
| +0.4% | +$1.14K |
|
235
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$47.1B
| $266K | 0.08% |
+2,900
| New | +$265K |
|
236
ProShares Short QQQ
PSQ
$824M
| $262K | 0.08% |
1,780
-140
| -7% | -$21.9K |
|
237
LyondellBasell Industries
LYB
$20B
| $259K | 0.08% |
3,085
+225
| +8% | +$19.4K |
|
238
Qualcomm
QCOM
$155B
| $259K | 0.08% |
4,538
-1,999
| -31% | -$108K |
|
239
Jefferies Financial Group
JEF
$12.6B
| $257K | 0.08% |
15,271
| – | – |
|
240
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.7B
| $255K | 0.08% |
4,660
+4
| +0.1% | +$211 |
|
241
Oneok
OKE
$57.2B
| $255K | 0.08% |
+3,650
| New | +$236K |
|
|
DHC
242
Diversified Healthcare Trust
DHC
$2.15B
| $252K | 0.08% |
21,414
-3,150
| -13% | -$40.3K |
|
243
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
| $250K | 0.07% |
2,268
+13
| +0.6% | +$1.4K |
|
244
iShares Russell 1000 Value ETF
IWD
$82.2B
| $249K | 0.07% |
2,020
+211
| +12% | +$25.4K |
|
245
iShares Core MSCI Emerging Markets ETF
IEMG
$150B
| $248K | 0.07% |
+4,789
| New | +$243K |
|
246
Invesco Value Municipal Income Trust
IIM
$589M
| $248K | 0.07% |
17,250
+5,850
| +51% | +$83.9K |
|
247
Lockheed Martin
LMT
$134B
| $242K | 0.07% |
807
+1
| +0.1% | +$293 |
|
248
Vanguard Morningstar Value ETF
VTV
$188B
| $242K | 0.07% |
+2,245
| New | +$236K |
|
249
Republic Services
RSG
$64.8B
| $241K | 0.07% |
2,995
-50
| -2% | -$3.85K |
|
250
iShares Gold Trust
IAU
$62.9B
| $236K | 0.07% |
9,525
-5,575
| -37% | -$139K |
|
Similar funds
AAM
F
GBS
C
FPCM
TC
SAS
PIM
Boenning & Scattergood's Q1 2019 Portfolio in Review
As of Q1 2019, Boenning & Scattergood held 289 positions worth $334M, up 17% from $287M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Boenning & Scattergood deployed $13.4M of net new capital in Q1 2019, opening 27 new positions and adding to 129 existing holdings. Its largest new stake was Target: 18,390 shares worth $1.48M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Universal Health Realty Income Trust, an estimated $5.13M trimmed.
- Boenning & Scattergood's largest Q1 2019 buy was Target: 18,390 shares worth $1.48M.
- Boenning & Scattergood added most to Vanguard FTSE Developed Markets ETF in Q1 2019, an estimated $2.41M increase.
- Boenning & Scattergood's biggest Q1 2019 reduction was Universal Health Realty Income Trust, cutting an estimated $5.13M.
- Boenning & Scattergood fully exited iShares Biotechnology ETF in Q1 2019, selling an estimated $1.13M.
- Boenning & Scattergood's ten largest holdings make up 24% of its $334M portfolio in Q1 2019.
- Boenning & Scattergood opened 27 new positions and closed 9 in Q1 2019.
- Boenning & Scattergood's portfolio value rose 17% quarter-over-quarter to $334M.
Based on Boenning & Scattergood's 13F filing for Q1 2019, filed 22 Apr 2019.